Prostate Cancer - Results from #1620

Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective-Prospective [68Ga]Ga-PSMA-11 PET/CT Study. December 20, 2023

Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment. December 20, 2023

Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer. December 20, 2023

Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries. December 19, 2023

MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing. December 19, 2023

A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer. December 19, 2023

Health-related quality of life among prostate cancer survivors with metastatic disease and non-metastatic disease and men without a cancer history in the USA. December 19, 2023

PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease. December 19, 2023

Assessment of Prostate and Bladder Cancer Genomic Biomarkers Using Artificial Intelligence: a Systematic Review. December 19, 2023

Prostate cancer genetic risk and associated aggressive disease in men of African ancestry. December 19, 2023

Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment. December 19, 2023

Prostate Cancer Patient Stratification by Molecular Signatures in the Veterans Precision Oncology Data Commons. December 19, 2023

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer December 18, 2023

Incidence trends in prostate cancer among men in the United States from 2000 to 2020 by race and ethnicity, age and tumor stage. December 18, 2023

Blood Pressure, Hypertension, and Antihypertensive Medication Use and Risk of Total and Fatal Prostate Cancer in Black and White Men in the Atherosclerosis Risk in Communities (ARIC) Study. December 18, 2023

Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer. December 18, 2023

Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study. December 18, 2023

Prostate-Specific Membrane Antigen-Targeted Therapies for Prostate Cancer: Towards Improving Therapeutic Outcomes. December 18, 2023

Feasibility of a novel wearable thermal device for management of bothersome hot flashes in patients with prostate cancer. December 15, 2023

Medium-term follow up of active surveillance for early prostate cancer at a non-academic institution. December 15, 2023

Page 82 of 1435